Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Perry

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?Michael C Perry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it?Michael C Perry
Cancer Biology & Therapy|September 26, 2003
Classical chemotherapy: mechanisms, toxicities and the therapeutic windowVikas Malhotra, Michael C Perry
Annals of Saudi Medicine|April 13, 2005
Lung cancerIrfan Maghfoor, Michael C Perry
Cancer Investigation|November 21, 2007
Epidermal growth factor receptor-targeted therapy for pancreatic cancerChris Papageorgio, Michael C Perry
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Meningeal Myeloma: A Case Report and Review of LiteratureIRFAN Maghfoor, MICHAEL C. Perry
Clinical Lung Cancer|May 10, 2011
History of small-cell lung cancerShadi Haddadin, Michael C Perry
Seminars in Oncology|February 14, 2006
Pulmonary toxicity of chemotherapyMark Meadors, Justin Floyd, Michael C Perry
Acta Oncologica (Stockholm, Sweden)|October 11, 2007
A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancerDaniel Morgensztern, Michael C Perry, Ramaswamy Govindan
Seminars in Oncology|February 14, 2006
Hepatotoxicity of chemotherapyJustin Floyd, Irfan Mirza, Bradley Sachs, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?Michael C Perry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Thoracic radiation therapy in limited stage small-cell lung cancer: timing is everything...isn't it?Michael C Perry
Cancer Biology & Therapy|September 26, 2003
Classical chemotherapy: mechanisms, toxicities and the therapeutic windowVikas Malhotra, Michael C Perry
Annals of Saudi Medicine|April 13, 2005
Lung cancerIrfan Maghfoor, Michael C Perry
Cancer Investigation|November 21, 2007
Epidermal growth factor receptor-targeted therapy for pancreatic cancerChris Papageorgio, Michael C Perry
Hematology (Amsterdam, Netherlands)|June 16, 2001
Malignancy: Meningeal Myeloma: A Case Report and Review of LiteratureIRFAN Maghfoor, MICHAEL C. Perry
Clinical Lung Cancer|May 10, 2011
History of small-cell lung cancerShadi Haddadin, Michael C Perry
Seminars in Oncology|February 14, 2006
Pulmonary toxicity of chemotherapyMark Meadors, Justin Floyd, Michael C Perry
Acta Oncologica (Stockholm, Sweden)|October 11, 2007
A phase II study of topotecan and docetaxel in patients with sensitive relapse small cell lung cancerDaniel Morgensztern, Michael C Perry, Ramaswamy Govindan
Seminars in Oncology|February 14, 2006
Hepatotoxicity of chemotherapyJustin Floyd, Irfan Mirza, Bradley Sachs, et al.
Pageof 5